Results 1 to 10 of about 281,021 (276)

Prevalence of peripheral arterial occlusive disease in patients referred to a tertiary care hospital in Salvador, Bahia, Brazil, for coronary angiography [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2008
The presence of peripheral arterial occlusive disease increases the morbidity and mortality of patients with coronary artery disease. The objective of the present study was to calculate the prevalence of peripheral arterial occlusive disease in patients ...
J.L.B. Nunes   +6 more
doaj   +3 more sources

Factors influencing quality of life following lower limb amputation for peripheral arterial occlusive disease: a systematic review of the literature [PDF]

open access: yesProsthetics and orthotics international, 2017
Background: The majority of lower limb amputations are undertaken in people with peripheral arterial occlusive disease,\ud and approximately 50% have diabetes.
Abdelgadir M   +31 more
core   +3 more sources

Platelet- derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study [PDF]

open access: gold, 2011
INTRODUCTION: Systemic sclerosis (SSc) complicated by pulmonary arterial hypertension (PAH) carries a poor prognosis, despite pulmonary vascular dilating therapy.
Berkel, M.P.A. van   +10 more
core   +5 more sources

Autoamputation of Toes in a Renal Transplant Recipient: Warning Sign of an Impending Graft Rejection? [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
The peripheral arterial occlusive disease is responsible for a significant amount of morbidity and mortality in patients of end-stage renal disease. This disease might not be as common as end-stage renal disease in vascular complications arising after ...
V Siva Kesava Reddy   +3 more
doaj   +1 more source

Clinical Use of Hydrogen Sulfide to Protect Against Intimal Hyperplasia

open access: yesFrontiers in Cardiovascular Medicine, 2022
Arterial occlusive disease is the narrowing of the arteries via atherosclerotic plaque buildup. The major risk factors for arterial occlusive disease are age, high levels of cholesterol and triglycerides, diabetes, high blood pressure, and smoking ...
Diane Macabrey   +7 more
doaj   +1 more source

Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral arterial disease, either peripheral arterial occlusive disease or thromboangiitis obliterans ...
Annie M Bérard   +21 more
doaj   +1 more source

Sex disparities in peripheral arterial occlusive disease

open access: yesAngiologia e Cirurgia Vascular, 2023
INTRODUCTION: Recently published studies on peripheral arterial occlusive disease (PAOD) have revealed marked sex disparities in patient selection and treatment outcomes.
Leonor Baldaia   +7 more
doaj   +1 more source

Intensive Rehabilitation Program in Arterial Occlusive Disease Patients

open access: yesApplied Sciences, 2021
Peripheral arterial occlusive disease (PAOD) limits walking efficiency and distance. The main disabling symptom is vasculopathy that leads to claudicatio intermittens and limits walking efficiency.
Luca Marin   +7 more
doaj   +1 more source

Antiphospholipid Syndrome-Induced Leriche Syndrome in a Man with Lower Limbs Sensory and Motor Defect

open access: yesJournal of Cardiovascular Development and Disease, 2021
Antiphospholipid syndrome (APS) is an autoimmune disorder with characteristics of arterial and/or venous thrombosis due to hypercoagulation status. Although deep vein thrombosis is common, the involvement of arterial thrombosis is more dangerous and ...
Jeng-Luen Hong   +6 more
doaj   +1 more source

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial [PDF]

open access: yes, 2019
Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage.
Al-Shahi Salman, Rustam   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy